Abstract
Summary
The global market for CAR-T Therapy was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for CAR-T Therapy was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for CAR-T Therapy was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for CAR-T Therapy was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of CAR-T Therapy include Novartis AG, Kite Pharma, Pfizer, Juno Therapeutics, Celgene Corporation, CARsgen Therapeutics, Sorrento Therapeutics, Legend Biotech and Atara Biotherapeutics, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for CAR-T Therapy, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of CAR-T Therapy by region & country, by Type, and by Application.
The CAR-T Therapy market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CAR-T Therapy.
Market Segmentation
By Company
Novartis AG
Kite Pharma
Pfizer
Juno Therapeutics
Celgene Corporation
CARsgen Therapeutics
Sorrento Therapeutics
Legend Biotech
Atara Biotherapeutics
Aurora Biopharma
Autolus Therapeutics PLC
Bluebird
Carina Biotech
Segment by Type:
CD19
CD22
Other
Segment by Application
Acute Lymphocytic Leukemia
Diffuse Large B Cell Lymphoma
Follicular Lymphoma
Chronic Lymphocytic Leukemia
Multiple Myeloma
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of CAR-T Therapy manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of CAR-T Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of CAR-T Therapy in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
North American market for CAR-T Therapy was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for CAR-T Therapy was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for CAR-T Therapy was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of CAR-T Therapy include Novartis AG, Kite Pharma, Pfizer, Juno Therapeutics, Celgene Corporation, CARsgen Therapeutics, Sorrento Therapeutics, Legend Biotech and Atara Biotherapeutics, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for CAR-T Therapy, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of CAR-T Therapy by region & country, by Type, and by Application.
The CAR-T Therapy market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CAR-T Therapy.
Market Segmentation
By Company
Novartis AG
Kite Pharma
Pfizer
Juno Therapeutics
Celgene Corporation
CARsgen Therapeutics
Sorrento Therapeutics
Legend Biotech
Atara Biotherapeutics
Aurora Biopharma
Autolus Therapeutics PLC
Bluebird
Carina Biotech
Segment by Type:
CD19
CD22
Other
Segment by Application
Acute Lymphocytic Leukemia
Diffuse Large B Cell Lymphoma
Follicular Lymphoma
Chronic Lymphocytic Leukemia
Multiple Myeloma
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of CAR-T Therapy manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of CAR-T Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of CAR-T Therapy in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 CAR-T Therapy Product Introduction
1.2 Global CAR-T Therapy Market Size Forecast
1.3 CAR-T Therapy Market Trends & Drivers
1.3.1 CAR-T Therapy Industry Trends
1.3.2 CAR-T Therapy Market Drivers & Opportunity
1.3.3 CAR-T Therapy Market Challenges
1.3.4 CAR-T Therapy Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global CAR-T Therapy Players Revenue Ranking (2023)
2.2 Global CAR-T Therapy Revenue by Company (2019-2024)
2.3 Key Companies CAR-T Therapy Manufacturing Base Distribution and Headquarters
2.4 Key Companies CAR-T Therapy Product Offered
2.5 Key Companies Time to Begin Mass Production of CAR-T Therapy
2.6 CAR-T Therapy Market Competitive Analysis
2.6.1 CAR-T Therapy Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by CAR-T Therapy Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR-T Therapy as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 CD19
3.1.2 CD22
3.1.3 Other
3.2 Global CAR-T Therapy Sales Value by Type
3.2.1 Global CAR-T Therapy Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global CAR-T Therapy Sales Value, by Type (2019-2030)
3.2.3 Global CAR-T Therapy Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Acute Lymphocytic Leukemia
4.1.2 Diffuse Large B Cell Lymphoma
4.1.3 Follicular Lymphoma
4.1.4 Chronic Lymphocytic Leukemia
4.1.5 Multiple Myeloma
4.1.6 Other
4.2 Global CAR-T Therapy Sales Value by Application
4.2.1 Global CAR-T Therapy Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global CAR-T Therapy Sales Value, by Application (2019-2030)
4.2.3 Global CAR-T Therapy Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global CAR-T Therapy Sales Value by Region
5.1.1 Global CAR-T Therapy Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global CAR-T Therapy Sales Value by Region (2019-2024)
5.1.3 Global CAR-T Therapy Sales Value by Region (2025-2030)
5.1.4 Global CAR-T Therapy Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America CAR-T Therapy Sales Value, 2019-2030
5.2.2 North America CAR-T Therapy Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe CAR-T Therapy Sales Value, 2019-2030
5.3.2 Europe CAR-T Therapy Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific CAR-T Therapy Sales Value, 2019-2030
5.4.2 Asia Pacific CAR-T Therapy Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America CAR-T Therapy Sales Value, 2019-2030
5.5.2 South America CAR-T Therapy Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa CAR-T Therapy Sales Value, 2019-2030
5.6.2 Middle East & Africa CAR-T Therapy Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions CAR-T Therapy Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions CAR-T Therapy Sales Value
6.3 United States
6.3.1 United States CAR-T Therapy Sales Value, 2019-2030
6.3.2 United States CAR-T Therapy Sales Value by Type (%), 2023 VS 2030
6.3.3 United States CAR-T Therapy Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe CAR-T Therapy Sales Value, 2019-2030
6.4.2 Europe CAR-T Therapy Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe CAR-T Therapy Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China CAR-T Therapy Sales Value, 2019-2030
6.5.2 China CAR-T Therapy Sales Value by Type (%), 2023 VS 2030
6.5.3 China CAR-T Therapy Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan CAR-T Therapy Sales Value, 2019-2030
6.6.2 Japan CAR-T Therapy Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan CAR-T Therapy Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea CAR-T Therapy Sales Value, 2019-2030
6.7.2 South Korea CAR-T Therapy Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea CAR-T Therapy Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia CAR-T Therapy Sales Value, 2019-2030
6.8.2 Southeast Asia CAR-T Therapy Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia CAR-T Therapy Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India CAR-T Therapy Sales Value, 2019-2030
6.9.2 India CAR-T Therapy Sales Value by Type (%), 2023 VS 2030
6.9.3 India CAR-T Therapy Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Novartis AG
7.1.1 Novartis AG Profile
7.1.2 Novartis AG Main Business
7.1.3 Novartis AG CAR-T Therapy Products, Services and Solutions
7.1.4 Novartis AG CAR-T Therapy Revenue (US$ Million) & (2019-2024)
7.1.5 Novartis AG Recent Developments
7.2 Kite Pharma
7.2.1 Kite Pharma Profile
7.2.2 Kite Pharma Main Business
7.2.3 Kite Pharma CAR-T Therapy Products, Services and Solutions
7.2.4 Kite Pharma CAR-T Therapy Revenue (US$ Million) & (2019-2024)
7.2.5 Kite Pharma Recent Developments
7.3 Pfizer
7.3.1 Pfizer Profile
7.3.2 Pfizer Main Business
7.3.3 Pfizer CAR-T Therapy Products, Services and Solutions
7.3.4 Pfizer CAR-T Therapy Revenue (US$ Million) & (2019-2024)
7.3.5 Juno Therapeutics Recent Developments
7.4 Juno Therapeutics
7.4.1 Juno Therapeutics Profile
7.4.2 Juno Therapeutics Main Business
7.4.3 Juno Therapeutics CAR-T Therapy Products, Services and Solutions
7.4.4 Juno Therapeutics CAR-T Therapy Revenue (US$ Million) & (2019-2024)
7.4.5 Juno Therapeutics Recent Developments
7.5 Celgene Corporation
7.5.1 Celgene Corporation Profile
7.5.2 Celgene Corporation Main Business
7.5.3 Celgene Corporation CAR-T Therapy Products, Services and Solutions
7.5.4 Celgene Corporation CAR-T Therapy Revenue (US$ Million) & (2019-2024)
7.5.5 Celgene Corporation Recent Developments
7.6 CARsgen Therapeutics
7.6.1 CARsgen Therapeutics Profile
7.6.2 CARsgen Therapeutics Main Business
7.6.3 CARsgen Therapeutics CAR-T Therapy Products, Services and Solutions
7.6.4 CARsgen Therapeutics CAR-T Therapy Revenue (US$ Million) & (2019-2024)
7.6.5 CARsgen Therapeutics Recent Developments
7.7 Sorrento Therapeutics
7.7.1 Sorrento Therapeutics Profile
7.7.2 Sorrento Therapeutics Main Business
7.7.3 Sorrento Therapeutics CAR-T Therapy Products, Services and Solutions
7.7.4 Sorrento Therapeutics CAR-T Therapy Revenue (US$ Million) & (2019-2024)
7.7.5 Sorrento Therapeutics Recent Developments
7.8 Legend Biotech
7.8.1 Legend Biotech Profile
7.8.2 Legend Biotech Main Business
7.8.3 Legend Biotech CAR-T Therapy Products, Services and Solutions
7.8.4 Legend Biotech CAR-T Therapy Revenue (US$ Million) & (2019-2024)
7.8.5 Legend Biotech Recent Developments
7.9 Atara Biotherapeutics
7.9.1 Atara Biotherapeutics Profile
7.9.2 Atara Biotherapeutics Main Business
7.9.3 Atara Biotherapeutics CAR-T Therapy Products, Services and Solutions
7.9.4 Atara Biotherapeutics CAR-T Therapy Revenue (US$ Million) & (2019-2024)
7.9.5 Atara Biotherapeutics Recent Developments
7.10 Aurora Biopharma
7.10.1 Aurora Biopharma Profile
7.10.2 Aurora Biopharma Main Business
7.10.3 Aurora Biopharma CAR-T Therapy Products, Services and Solutions
7.10.4 Aurora Biopharma CAR-T Therapy Revenue (US$ Million) & (2019-2024)
7.10.5 Aurora Biopharma Recent Developments
7.11 Autolus Therapeutics PLC
7.11.1 Autolus Therapeutics PLC Profile
7.11.2 Autolus Therapeutics PLC Main Business
7.11.3 Autolus Therapeutics PLC CAR-T Therapy Products, Services and Solutions
7.11.4 Autolus Therapeutics PLC CAR-T Therapy Revenue (US$ Million) & (2019-2024)
7.11.5 Autolus Therapeutics PLC Recent Developments
7.12 Bluebird
7.12.1 Bluebird Profile
7.12.2 Bluebird Main Business
7.12.3 Bluebird CAR-T Therapy Products, Services and Solutions
7.12.4 Bluebird CAR-T Therapy Revenue (US$ Million) & (2019-2024)
7.12.5 Bluebird Recent Developments
7.13 Carina Biotech
7.13.1 Carina Biotech Profile
7.13.2 Carina Biotech Main Business
7.13.3 Carina Biotech CAR-T Therapy Products, Services and Solutions
7.13.4 Carina Biotech CAR-T Therapy Revenue (US$ Million) & (2019-2024)
7.13.5 Carina Biotech Recent Developments
8 Industry Chain Analysis
8.1 CAR-T Therapy Industrial Chain
8.2 CAR-T Therapy Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 CAR-T Therapy Sales Model
8.5.2 Sales Channel
8.5.3 CAR-T Therapy Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer